94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Dan Sexton1,†
Ryan Faucette1,†Melody Rivera-Hernandez1,†Jon A. Kenniston1,†Nikolaos Papaioannou1,†
Janja Cosic1Kris Kopacz1Gary Salmon2
Chantal Beauchemin1Salomé Juethner3
Dave Yeung1*
- 1Takeda Development Center Americas Inc., Cambridge, MA, United States
- 2Charles River Laboratories, Harlow, United Kingdom
- 3Takeda Pharmaceuticals USA, Inc., Lexington, MA, United States
A corrigendum on
A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema
By Sexton D, Faucette R, Rivera-Hernandez M, Kenniston JA, Papaioannou N, Cosic J, Kopacz K, Salmon G, Beauchemin C, Juethner S and Yeung D (2024). Front. Allergy. 5:1436855. doi: 10.3389/falgy.2024.1436855
Incorrect Copyright Statement
In the published article, there was an error in the Copyright statement. The statement was incorrectly written as “Copyright © 2024 Sexton, Faucette, Rivera-Hernandez, Kenniston, Papaioannou, Cosic, Kopacz, Salmon, Beauchemin, Juethner and Yeung”. The corrected statement is “This work is authored by Sexton, Faucette, Rivera-Hernandez, Kenniston, Papaioannou, Cosic, Kopacz, Salmon, Beauchemin, Juethner, and Yeung. © 2024 Takeda Pharmaceuticals USA Inc. for Sexton, Faucette, Rivera-Hernandez, Kenniston, Papaioannou, Cosic, Kopacz, Salmon, Beauchemin, Juethner, and Yeung”. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original authors and the copyright owner are credited and the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: biomarkers, phage display, bradykinin, plasma kallikrein, hereditary angioedema
Citation: Sexton D, Faucette R, Rivera-Hernandez M, Kenniston JA, Papaioannou N, Cosic J, Kopacz K, Salmon G, Beauchemin C, Juethner S and Yeung D (2025) Corrigendum: A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema. Front. Allergy 6:1557356. doi: 10.3389/falgy.2025.1557356
Received: 8 January 2025; Accepted: 23 January 2025;
Published: 14 February 2025.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright: This work is authored by Sexton, Faucette, Rivera-Hernandez, Kenniston, Papaioannou, Cosic, Kopacz, Salmon, Beauchemin, Juethner, and Yeung. © 2025 Takeda Pharmaceuticals USA Inc. for Sexton, Faucette, Rivera-Hernandez, Kenniston, Papaioannou, Cosic, Kopacz, Salmon, Beauchemin, Juethner, and Yeung. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Dave Yeung, ZGF2ZS55ZXVuZ0B0YWtlZGEuY29t
†Affiliation at the time of the study